Avid Bioservices Inc Asset Turnover Ratio (CDMO), as of second quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Avid Bioservices Inc   (NASDAQ: CDMO)
 

Avid Bioservices Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Avid Bioservices Inc asset turnover ratio, the ability of Avid Bioservices Inc 's assets to generate revenue in the second quarter 2025, increased sequentially to 0.47 in the second quarter (Oct 31 2024), CDMO's balance sheet remain strong.

Within sector 90 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Second Quarter 2025 compared to the preceding quarter from 1460 to 2274.

Asset Turnover Ratio Definition



CDMO Asset Turnover Ratio (Oct 31 2024)
II. Quarter
(Jul 31 2024)
I. Quarter
(Apr 30 2024)
IV. Quarter
(Jan 31 2024)
III. Quarter
(Oct 31 2023)
II. Quarter
Y / Y Asset Change -31.64 % -26.59 % -27.96 % -0.37 % 1.9 %
Y / Y Revenue Change 32.16 % 8.28 % 11.5 % -12.19 % -27.11 %
Asset Turnover Ratio (TTM) 0.47 0.4 0.36 0.33 0.34
CDMO's Total Ranking # 2274 # 1460 # 2264 # 2653 # 2658
Seq. Asset Change -3.89 % -0.09 % -28.81 % 0.01 % 3.21 %
Seq. Revenue Change -16.66 % -7.65 % 30.31 % 31.77 % -31.71 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 91
Healthcare Sector # 331
Overall Market # 2274

Asset Turnover Ratio Statistics
High Average Low
0.72 0.46 0.26
(Jul 31 2017)   (Oct 31 2014)







Companies with similar Asset Turnover Ratio for the quarter ending Oct 31 2024, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Oct 31 2024 Assets at quarter ending Oct 31 2024
Mimedx Group Inc   1.46 $ 340.641  Millions$ 233.701  Millions
Option Care Health Inc   1.44 $ 4,774.651  Millions$ 3,310.729  Millions
Vycor Medical Inc   1.43 $ 1.441  Millions$ 1.008  Millions
Chemed Corporation  1.38 $ 2,377.206  Millions$ 1,725.037  Millions
Biolase Inc   1.37 $ 43.720  Millions$ 31.834  Millions
Evofem Biosciences Inc   1.33 $ 17.098  Millions$ 12.816  Millions
Viemed Healthcare Inc   1.33 $ 214.301  Millions$ 160.811  Millions
Sanuwave Health Inc   1.32 $ 29.302  Millions$ 22.149  Millions
Trisalus Life Sciences Inc   1.31 $ 33.879  Millions$ 25.880  Millions
Talkspace Inc   1.30 $ 179.853  Millions$ 138.130  Millions
Bioaffinity Technologies Inc   1.27 $ 9.368  Millions$ 7.370  Millions
Infusystem Holdings Inc  1.26 $ 132.784  Millions$ 105.399  Millions
Marpai Inc  1.26 $ 30.093  Millions$ 23.930  Millions
Adm Tronics Unlimited Inc   1.24 $ 3.146  Millions$ 2.536  Millions
Rigel Pharmaceuticals Inc  1.23 $ 157.474  Millions$ 127.893  Millions
Electrocore Inc   1.22 $ 22.458  Millions$ 18.348  Millions
Warby Parker Inc   1.22 $ 740.597  Millions$ 607.350  Millions
Hca Healthcare Inc   1.21 $ 69,621.000  Millions$ 57,502.750  Millions
Aveanna Healthcare Holdings Inc   1.21 $ 1,983.475  Millions$ 1,641.142  Millions
Henry Schein Inc   1.20 $ 12,499.000  Millions$ 10,393.500  Millions
Xtant Medical Holdings Inc   1.19 $ 112.922  Millions$ 95.251  Millions
Atara Biotherapeutics Inc   1.18 $ 174.462  Millions$ 147.692  Millions
Nrc Health  1.17 $ 144.154  Millions$ 123.561  Millions
Electromed Inc   1.17 $ 57.060  Millions$ 48.964  Millions
Koru Medical Systems Inc   1.16 $ 31.994  Millions$ 27.664  Millions
Idexx Laboratories Inc  1.15 $ 3,843.430  Millions$ 3,344.768  Millions
Regen Biopharma Inc   1.15 $ 0.237  Millions$ 0.206  Millions
Dynatronics Corporation  1.14 $ 30.784  Millions$ 27.017  Millions
Mettler toledo International Inc   1.14 $ 3,762.226  Millions$ 3,301.916  Millions
Nephros Inc   1.13 $ 12.683  Millions$ 11.191  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.